Current situation of treatment and research progress of fetal congenital heart disease
10.3760/cma.j.cn112434-20200803-00359
- VernacularTitle:胎儿先天性心脏病的治疗现状和研究进展
- Author:
Yun TENG
1
;
Bingxin HUANG
;
Jimei CHEN
Author Information
1. 广东省人民医院（广东省医学科学院）心外科，广州 510080
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2021;37(7):443-446
- CountryChina
- Language:Chinese
-
Abstract:
Congenital heart disease is one of the most common birth defects, and its structural changes often require surgical or non-surgical intervention after delivery. Some scholars believe that because early primary intrauterine heart abnormalities may hinder the normal development of the heart and cause irreversible secondary structural changes, the current treatment of congenital heart disease focuses on prenatal diagnosis and fetal intervention. Since the first successful fetal surgery in 1984, and with the development and progress of diagnostic techniques such as fetal cardiac ultrasound, the treatment of congenital heart disease has gradually become the focus of research. This article will focus on the intrauterine cardiac intervention of a specific type of congenital heart disease, fetal cardiac surgery guided by fetal scope, the impact of cardiopulmonary bypass on the fetus or the mother, intrauterine cardiac surgery and targeted therapy of fetal congenital heart disease are summarized in this article.
